On January 5, 2022 UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat urothelial and specialty cancers, reported that it will present at the following virtual healthcare conferences in January (Press release, UroGen Pharma, JAN 5, 2022, View Source [SID1234598244]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

40th Annual J.P. Morgan Healthcare Conference

Thursday, January 13 at 9:45 a.m. ET
HC Wainwright BioConnect Conference

Presentation available on-demand beginning Monday, January 10 at 7:00 a.m. ET
Webcasts of both the J.P. Morgan and HC Wainwright presentations will be available via the Investors section of UroGen’s website, www.urogen.com. A replay of each webcast will be available on the Company’s website for approximately 30 days.